Our team advises clients on the full spectrum of antitrust issues in the US, EU and other significant antitrust jurisdictions globally.
We offer clients deep experience in a range of industries, including energy, transportation, technology, pharmaceuticals and healthcare, financial services, insurance, manufacturing, agriculture, consumer products, and media and communications. Our attorneys have held senior positions at US federal agencies and regularly provide counseling to clients in these and other sectors on a wide variety of antitrust topics.
Our multidisciplinary teams of trial and antitrust lawyers handle multijurisdictional investigations and government and private litigation before antitrust enforcement agencies and tribunals worldwide. We regularly counsel clients on antitrust issues in pricing, distribution and licensing arrangements, patent pools, standard setting activities, information exchanges and other business activities. Clients trust us to handle their most complex, strategic deals and matters that require experience, good judgment and practical, commercially attuned solutions.
We pursue conventional trial practice when a trial is necessary or strategically advantageous, leveraging our extensive experience working with seasoned testifying experts and leading economic consulting firms and developing strategies to defeat class certification. And when it best serves the goals of our clients, we will turn to alternative dispute resolution, including mediation and arbitration, or negotiate a settlement on the best possible terms.
Milbank attorneys have:
- successfully defended clients in treble-damages US class action price-fixing litigation, monopolization claims and other government and private US civil actions—frequently coordinating global strategy in parallel litigation and regulatory proceedings brought around the world;
- litigated some of the most significant federal and state challenges to mergers in recent years;
- and guided clients through antitrust investigations by the US Department of Justice Antitrust Division, Federal Trade Commission and other antitrust authorities around the world.
Our lawyers are recognized authorities and thought leaders, providing insightful analysis on numerous topics, including an examination of “What's at Stake for Mergers, Antitrust and CFIUS in the US 2024 Presidential Election,” the FTC and DOJ issuing the final revised version of their Merger Guidelines, a look at the FTC’s most high-profile antitrust cases, and core chapters in leading publications addressing antitrust issues in Germany (Panoramic) and the UK (Lexology).
The team’s notable recent representations include:
- SEACOR on its successful formation and launch of Fairwater Holdings
- Roche on the completion of its acquisition of LumiraDx’s point of care technology via an English pre-pack administration sale
- Summit Partners on its investments in Revizto and OneStock
- SLB as antitrust counsel on its $7.8 billion acquisition of ChampionX
The firm’s Antitrust practice and its members are regularly recognized by Chambers, The Legal 500, Global Competition Review and Benchmark Litigation.
“They provide top-notch legal representation from start to finish. The entire team of partners and associates supplied us with zealous representation and an impeccable performance.” – Chambers USA
